Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells

Journal of Neuroimmunology

Volumn 175, Issue 1-2, 2006, Pages 12-18

  Ben Hur, Tamir ^a   Ben Yosef, Yaara ^b   Mizrachi Kol, Rachel ^a   Ben Menachem, Ofra ^a   Miller, Ariel ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Cytokines; MMP; Multiple sclerosis; NPC; TIMP

Indexed keywords

BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NESTIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; NERVE CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STRIATE CORTEX; UPREGULATION; ZYMOGRAPHY;

ANIMALS; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; ENZYME INDUCTION; GELATINASES; INTERFERON TYPE II; INTERFERON-BETA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEURONS; RATS; RATS, INBRED LEW; RNA, MESSENGER; STEM CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646872221     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.02.002     Document Type: Article

References (33)

1. Abraham M., Shapiro S., Lahat N., and Miller A. The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells. Int. Immunol. 14 (2002) 1449-1457
2. Abraham M., Shapiro S., Karni A., Weiner H.L., and Miller A. Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells. J. Neuroimmunol. 163 (2005) 157-164
3. Avanzini M.A., Ciardelli L., Lenta E., Castellazzi A.M., Marconi M., Deroso G., Dos Santos C., Oliveri M., Pistorio A., Lorini R., and d'Annuzio G. IFN-gamma low production capacity in type I diabetes mellitus patients at onset of disease. Exp. Clin. Endocrinol. Diabetes 113 (2005) 313-317
4. Ben-Hur T., Ben-Menachem O., Furer V., Einstein O., Mizrachi-Kol R., and Grigoriadis N. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol. Cell. Neurosci. 24 (2003) 623-631
5. Ben-Hur T., Einstein O., Mizrachi-Kol R., Ben-Menachem O., Reinhartz E., Karussis D., and Abramsky O. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41 (2003) 73-80
6. Ben-Hur T., Einstein, and Bulte J.W. Stem cell therapy for myelin diseases. Curr. Drug Targets 6 (2005) 3-19
7. Ben-Yosef Y., Lahat N., Shapiro S., Bitterman H., and Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res. 19 (2002) 784-791
8. Borden P., and Heller R.A. Transcriptional control of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7 (1997) 159-178
9. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J. Neurosci. Res. 68 (2002) 501-510
10. Crockard A.D., Treacy M.T., Droogan A.G., and Hawkins S.A. Methylprednisolone attenuates interferon-β induced expression of HLA-DR on monocytes. J. Neuroimmunol. 70 (1996) 29-35
11. Duncan I.D., Grever W.E., and Zhang S.C. Repair of myelin disease: strategies and progress in animal models. Mol. Med. Today 3 (1997) 554-561
12. Fassina G., Ferrari N., Brigati C., Benelli R., Santi L., Noonan D.M., and Albini A. Tissue inhibitors of metalloproteinases: regulation and biological activities. Clin. Exp. Metastasis 18 (2000) 111-120
13. Galboiz Y., Shapiro S., Lahat N., Rawashdeh H., and Miller A. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-β therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann. Neurol. 50 (2001) 443-451
14. Galboiz Y., Shapiro S., Lahat N., and Miller A. Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-γ and -β: implications to multiple sclerosis. J. Neuroimmunol. 131 (2002) 191-200
15. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74 (1997) 111-122
16. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., and Khoury S. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. 52 (2004) 18117-18122
17. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. (2002) 1115-1121
18. Kieseier B.C., Seifert T., Giovannoni G., and Hartung H.P. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 13 53 (1999) 20-25
19. Lalive P.H., Paglinawan R., Biollaz G., Kappos E.A., Leone D.P., Malipiero U., Relvas J.B., Moransard M., Suter T., and Fontana A. TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur. J. Immunol. 35 (2005) 727-737
20. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., and Hauser S.L. Interferon β-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40 (1996) 846-852
21. Miller A., Lanir N., Shapiro S., Revel M., Honigman S., Kinarty A., and Lahat N. Immunoregulatory effects of interferon-β and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis. J. Neuroimmunol. 64 (1996) 151-161
22. Miller A., Shapiro S., Lahat N., and Galboiz Y. Matrix metalloproteinases and their inhibitors in brain injury and repair. In: Abramsky O., Compston A., Miller A., and Said G. (Eds). Brain Disease: Therapeutic Strategies and Repair (2002), Martin Dunitz Publishers, London 63-68
23. Nagase H., and Woessner J.F.J.R. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
24. Opdenakker G., Van den Steen P.E., and Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22 (2001) 571-579
25. Picard-Riera N., Decker L., Delarasse C., Goude K., Nait-Oumesmar B., Liblau R., Pham-Dinh D., and Evercooren A.B. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13211-13216
26. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., and Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436 (2005) 266-271
27. Satoh J., and Kuroda Y. Differing effects of IFN β vs IFNγ in MS: gene expression in cultured astrocytes. Neurology 57 (2001) 681-685
28. Shaked I., Tchoresh D., Gersner R., Meiri G., Mordechai S., Xiao X., Hart R.P., and Schwartz M. Protective autoimmunity: interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 92 (2005) 997-1009
29. Swallow C.J., Murray M.P., and Guillem J.G. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin. Exp. Metastasis 14 (1996) 3-11
30. Uhm J.H., Dooley N.P., Stuve O., Francis G.S., Duquette P., Antel J.P., and Yong V.W. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon β-1b therapy. Ann. Neurol. 46 (1999) 319-324
31. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
32. Wu J.P., Kuo J.S., Liu Y.L., and Tzeng S.F. Tumor necrosis factor-α modulates the proliferation of neural progenitors in the subventricular/ventricular zone of adult rat brain. Neurosci. Lett. 292 (2000) 203-206
33. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. 2 (2001) 502-511